Perforin-2 restricts growth of chlamydia trachomatis in macrophages

Infection and Immunity

Volumn 81, Issue 8, 2013, Pages 3045-3054

  Fields, K A ^a   McCormack, R ^a   de Armas, L R ^a   Podack, E R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFORIN; PERFORIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; EPITHELIUM CELL; HELA CELL; HOST CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; TRANSMISSION ELECTRON MICROSCOPY;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; IMMUNOBLOTTING; MACROPHAGES; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PORE FORMING CYTOTOXIC PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFECTION;

EID: 84880834181     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00497-13     Document Type: Article

References (47)

1. Morrison RP, Caldwell HD. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70:2741-2751.
2. Abdelrahman YM, Belland RJ. 2005. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29:949-959.
3. Hybiske K, Stephens RS. 2007. Mechanisms of host cell exit by the intra-cellular bacterium Chlamydia. Proc. Natl. Acad. Sci. U. S. A. 104:11430-11435.
4. Moulder JW. 1991. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55:143-190.
5. Fields KA, Hackstadt T. 2002. The chlamydial inclusion: escape from the endocytic pathway. Annu. Rev. Cell Dev. Biol. 18:221-245.
6. Betts HJ, Wolf K, Fields KA. 2009. Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal. Curr. Opin. Microbiol. 12: 81-87.
7. Valdivia RH. 2008. Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr. Opin. Microbiol. 11:53-59.
8. Fields KA. 2012. Secretion mechanisms and Chlamydia pathogenesis, p 192-216. In Tan M, Bavoil P (ed), Intracellular pathogens. I. Chlamydia-les. ASM Press, Washington, DC.
9. Morrison SG, Morrison RP. 2000. In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect. Immun. 68:2870-2879.
10. Darville T, Hiltke TJ. 2010. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J. Infect. Dis. 201:S114-S125.
11. Beagley K, Huston W, Hansbro P, Timms P. 2009. Chlamydial infection of immune cells: altered function and implications for disease. Crit. Rev. Immunol. 29:275-305.
12. Sun HS, Eng EWY, Jeganathan S, Sin AT-W, Patel PC, Gracy E, Inman RD, Terebiznik MR, Harrision RE. 2012. Chlamydia trachomatis vacuole maturation in infected macrophages. J. Leukoc. Biol. 92:815-827.
13. Yasir M, Pachikara ND, Bao X, Pan Z, Fan H. 2011. Regulation of chlamydial infection by host autophagy and vacuolar ATPase-bearing or-ganelles. Infect. Immun. 79:4019-4028.
14. Al-Zeer MA, Al-Younes HM, Lauster D, Abu Lubad M, Meyer TF. 2013. Autophagy restricts Chlamydia trachomatis growth in human macro-phages via IFNG-inducible guanylate binding proteins. Autophagy 9:50-62.
15. Spilsbury K, O'Mara M, Wu W, Rowe P, Symonds G, Takayama Y. 1995. Isolation of a novel macrophage-specific gene by differential cDNA analysis. Blood 85:1620-1629.
16. Wiens M, Korzhev M, Krasko A, Thakur NL, Perović-Ottstadt S, Breter HJ, Ushijima H, Diehl-Seifert B, Muller IM, Muller WE. 2005. Innate immune defense of the sponge Suberites domuncula against bacteria involves a MyD88-dependent signaling pathway. Induction of a perforin-like molecule. J. Biol. Chem. 280:27949-27959.
17. McCormack R, de Armas LR, Shiratsuchi M, Ramos JE, Podack ER. 2013. Inhibition of intracellular bacterial replication in fibroblasts is dependent on the perforin-like protein (perforin-2) encoded by mac-rophage-expressed gene 1. J. Innate Immun. 5:185-194.
18. Wolf K, Fischer E, Hackstadt T. 2005. Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells. Infect. Immun. 73:4560-4570.
19. Caldwell HD, Kromhout J, Schachter J. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia tra-chomatis. Infect. Immun. 31:1161-1176.
20. Furness G, Graham DM, Reeve P. 1960. The titration of trachoma and inclusion blennorrhoea viruses in cell cultures. J. Gen. Microbiol. 23:613-619.
21. LaemmliUK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA. 1996. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J. 15:964-977.
23. Carabeo R, Grieshaber S, Fischer E, Hackstadt T. 2002. Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect. Immun. 70:3793-3803.
24. Scidmore-Carlson MA, Shaw El, Dooley CA, Fischer ER, Hackstadt T. 1999. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol. Microbiol. 33:753-765.
25. Perry LL, Su H, Feilzer K, Messer R, Hughes S, Whitmire W, Caldwell HD. 1999. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-γ-mediated inhibition. J. Immunol. 162:3541-3548.
26. Chen AL, Johnson KA, Lee JK, Siitterlin C, Tan M. 2012. CPAF: a chlamydial protease in search of an authentic substrate. PLoS Pathog. 8:e1002842. doi: 10.1371/journal.ppat.1002842.
27. Lichtenheld MG, Olsen KJ, Lu P, Lowrey DM, Hameed A, Hengartner H, Podack ER. 1988. Structure and function of human perforin. Nature 335:448-451.
28. DiScipio RG, Gehring MR, Podack ER, Kan CC, Hugli TE, Fey GH. 1984. Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9. Proc. Natl. Acad. Sci. U. S. A. 81: 7298-7302.
29. Podack ER, Tschopp J. 1982. Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc. Natl. Acad. Sci. U. S. A. 79:574-578.
30. Law RHP, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, Dunstone MA, D'Angelo ME, Orlova EV, Coulibaly F, Verschoor S. 2010. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468:447-451.
31. Baran K, Dunstone M, Chia J, Ciccone A, Browne KA, Clarke CP, Lukoyanova N, Saibil H, Whisstock JC, Vosoboinik I. 2009. The molecular basis for perforin oligomerization and transmembrane pore assembly. Immunity 30:684-695.
32. Elwell CA, Engel JN. 2012. Lipid acquisition by intracellular chlamydiae. Cell. Microbiol. 14:1010-1018.
33. Yong EC, Chi EY, Kuo CC. 1987. Differential antimicrobial activity of human mononuclear phagocytes against the human biovars of Chlamydia trachomatis. J. Immunol. 139:1297-1302.
34. Wyrick PB, Brownridge EA, Ivins BE. 1978. Interaction of Chlamydia psittaci with mouse peritoneal macrophages. Infect. Immun. 19:1061-1067.
35. Nagarajan UM, Ojcius DM, Stahl L, Rank RG, Darville T. 2005. Chlamydia trachomatis induces expression of IFN-7-inducible protein 10 and IFN-γ-independent of TLR2 and TLR4, but largely dependent on MyD88. J. Immunol. 175:450-460.
36. Rank RG, Whittum-Hudson JA. 2010. Protective immunity to chlamydial genital infection: evidence from animal studies. J. Infect. Dis. 201: S168-S177.
37. Beatty WL, Morrison RP, Byrne GI. 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58:686-699.
38. Wyrick PB. 2010. Chlamydia trachomatis persistence in vitro: an overview. J. Infect. Dis. 201:S88-S95.
39. Roshick C, Wood H, Caldwell HD, McClarty G. 2006. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect. Immun. 74:225-238.
40. Morrison RP. 2000. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect. Immun. 68: 6038-6040.
41. Nagarajan UM, Sikes J, Prantner D, Andrews CW, Frazer L, Goodwin A, Snowden JN, Darville T. 2011. MyD88 deficiency leads to decreased NK cell gamma interferon production and T cell recruitment during Chlamydia muridarum genital tract infection, but a predominant Th1 response and enhanced monocytic inflammation are associated with infection resolution. Infect. Immun. 79:486-498.
42. Igietseme JU, Perry LL, Ananaba GA, Uriri IM, Ojior OO, Kumar SN, Caldwell HD. 1998. Chlamydial infection in inducible nitric oxide syn-thase knockout mice. Infect. Immun. 66:1282-1286.
43. Perry LL, Feilzer K, Caldwell HD. 1998. Neither interleukin-6 nor inducible nitric oxide synthase is required for clearance of Chlamydia trachomatis from the murine genital tract epithelium. Infect. Immun. 66: 1265-1269.
44. Ramsey KH, Miranpuri GS, Poulsen CE, Marthakis NB, Braune LM, Byrne GI. 1998. Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture. Infect. Immun. 66:835-838.
45. Ramsey KH. 2001. Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals. Infect. Immun. 69:7374-7379.
46. D'Angelo M, Dunstone M, Whisstock J, Trapani J, Bird P. 2012. Perforin evolved from a gene duplication of MPEG1, followed by a complex pattern of gene gain and loss within Euteleostomi. BMC Evol. Biol. 12:59. doi: 10.1186/1471-2148-12-59.
47. Clarke IN. 2011. Evolution of Chlamydia trachomatis. Ann. N. Y. Acad. Sci. 1230:E11-E18.